A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

Clinical trial NCT00412321 · COMPLETED

Trial details

NCT number: NCT00412321
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Multiple Myeloma Giant Lymph Node Hyperplasia

Start date: 2005-05-01
Primary completion: 2011-04-01
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.